ABBOTT LABORATORIES (NYSE: ABT) is included among the The best retirement actions for a portfolio of dividend shares.
Photo of Dannis in Unspash
ABBOTT Laboratories (NYSE: ABT) operates a large business that covers four main areas: medical devices, established pharmaceutical products, diagnoses and nutrition. With a strong global presence, its diversified structure helps balance performance when a segment experiences weakness.
ABBOTT Laboratories (NYSE: ABT) also sees several important long -term growth opportunities. Among the most promising is its free -style product line, a continuous glucose monitoring system that allows people with diabetes to track blood sugar levels. This has been a leading growth engine for Abbott and still has a considerable space to expand. In addition, the company continues to advance through continuous innovation and obtaining approvals for new medical devices.
ABBOTT Laboratories (NYSE: ABT) is a solid dividend company. On September 19, the company declared a quarterly dividend of $ 0.59 per share, which was in line with its previous dividend. In general, it has been rewarding shareholders with increasing dividends for 53 consecutive years, which makes Abt one of the best actions for a portfolio of dividend shares. As of September 21, the action has a 1.73%dividend yield.
While we recognize abt’s potential as an investment, we believe that certain AI actions offer greater upward potential and have less down risk. If you are looking for an extremely undervalued action that also benefits significantly from the Trump era tariffs and the wave trend, see our free report on the The best short -term AI actions.
Read below: 10 best S&P 500 dividend shares to invest in and 10 safer dividend shares to buy now
Disclosure: None.
(Tagstotranslate) Abbott Laboratories (T) Dividend Stock portfolio (T)
Source link